Biography:
Dr. Xiaodong Li received his PhD degree at University of Rochester, School of Medicine and Dentistry in 2007. After postdoctoral research in National Institutes of Health, he joined the multiple pharmaceutical companies, such as Hana Biosciences, NeurogesX, MAP Pharmaceuticals, and Allergan with increasing responsibilities. Dr. Li has published more than 30 peer-reviewed journal articles and conference abstracts. Dr. Xiaodong Li and Dr. Biao Lu co-founded LUXENA Pharmaceuticals, Inc. in 2013, which had since then developed multiple systemic inhalation delivery products.
Title : The critical role of lung safety in regulatory approval of systemic inhalation delivery products